How does Dapagliflozin work? Understanding SGLT2 inhibitors.

(6:57)

SGLT2 Inhibitors Mechanism of Action

(1:44)

Part 6 - Primary Care Insights from the KDIGO CKD Guideline: SGLT2 Inhibitors

(2:49)

SGLT2 Inhibitors and Heart Failure

(8:15)

When Should We Use SGLT2 Inhibitors?

(12:28)

Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists

(7:43)

Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'

(35:24)

Episode 12 - CMR and Cardiac Dysfunction in CKD, SGLT2i in Alport Syndrome, and MN Recurrence in KTX

(3:58)

SGLT2 Inhibitors in Chronic Kidney Disease

(9:6)

Cardiovascular Benefit With SGLT2 Inhibition

(2:27)

SGLT2 Inhibitors: Can these drugs slow the progression of chronic kidney disease?

(49:14)

Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists

(6:11)

SGLT2 Inhibitors in Heart Failure Management with Dr. John McMurray

(20:13)

SGLT2 inhibition in type 1 diabetes patients | John Wilding

(3:44)

SGLT2 Inhibitors are Associated With Reduced CV Disease in Type 2 Diabetes

(5:7)

Using SGLT2-inhibitors to treat cardiac patients with diabetes

(13:49)

The Implications of the Latest Data on SGLT2 Inhibitors in Heart Failure: A Unified Approach to T...

(29:16)

Jeffrey Berger, MD: Deciding Between GLP1 Agonists or SGLT2 Inhibitors

(2:51)

SGLT2 Inhibitors in Patients Without Diabetes at Risk of HF

(8:28)

SGLT2 inhibition in type 1 diabetes | Lori Berard

(1:53)